Balyasny Asset Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,438
Closed -$94.1K 2821
2025
Q1
$94.1K Sell
24,438
-22,007
-47% -$91.4K ﹤0.01% 2686
2024
Q4
$179K Buy
46,445
+16,545
+55% +$91.3K ﹤0.01% 2543
2024
Q3
$219K Buy
+29,900
New +$196K ﹤0.01% 2535
2024
Q2
Sell
-36,671
Closed -$386K 2572
2024
Q1
$386K Buy
+36,671
New +$299K ﹤0.01% 2164
2018
Q1
Sell
-54,542
Closed -$1.43M 1936
2017
Q4
$1.43M Buy
+54,542
New +$1.56M ﹤0.01% 1243

Other funds holding BAK

Balyasny Asset Management's BAK Position: Q2 2025 in Review

Balyasny Asset Management sold out of Braskem (BAK) in Q2 2025, closing a stake of 24,438 shares — an estimated $94.1K sold.

Balyasny Asset Management first reported a position in BAK in Q4 2017 and held it in 5 quarters. The position peaked at $1.43M in Q4 2017. 52 funds tracked by Wall St. Rank hold BAK as of Q2 2025.

  • Balyasny Asset Management reported no remaining Braskem position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 24,438 Braskem shares in Q2 2025, an estimated $94.1K.
  • Balyasny Asset Management first reported a position in Braskem in Q4 2017 and held it in 5 quarters.
  • Balyasny Asset Management's Braskem position peaked at $1.43M in Q4 2017.
  • 52 funds tracked by Wall St. Rank held Braskem as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.